Login
$EPRX
$7.34 -$0.81 (9.94%) Live

Who owns Eupraxia?

Institutions own
—
of the economics
—
of the votes

Refinery has not recorded this company's share classes yet, so ownership cannot be shown across them.

By class
Class Shares outstanding Held by institutions Votes a share Economics a share
EPRX — — 1 vote 1

How is ownership changing?

Institutions, last 8 quarters

A trend across this company's share classes isn't available yet: each quarter's 13F filings add up shares of classes that differ in economics and votes.

Biggest buyers in Q2 2026
  • Jupiter Topco LLC NEW +1.0M
  • PFM Health Sciences, LP +669.8K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Squadron Capital Management LLC SOLD OUT −680.0K
  • Ally Bridge Group (NY) LLC −408.2K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for EUPRAXIA PHARMACEUTICALS INC. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2025
+107.2%
+27.48% a year
Each share's claim on the business
−51.7%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $14.8M
over 4 fiscal years
Diluted shares, split-adjusted
18.7M29.5M40.4M2022: 19.3M shares'222023: 24.1M shares'232024: 33.9M shares'242025: 40.0M shares'25
Buybacks Stock-based comp
$0$4.4M$8.8M2022 buybacks: $02022 stock comp: $1.4M'222023 buybacks: $02023 stock comp: $1.4M'232024 buybacks: $02024 stock comp: $3.2M'242025 buybacks: $02025 stock comp: $8.8M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years12% Under 1 year88%
Quarterly turnover
18.4%
of institutional shares changed hands
Top 10 managers, median time held
3 quarters

Super Investors

Investment managers reporting Eupraxia on Form 13F
BG
Beutel, Goodman & Co Ltd.
Shares
3.6M
% of company
—
Change vs last qtr
−38.6K (−1.1%)
Held since
Q3 '25
AA
Affinity Asset Advisors, LLC
Shares
1.7M
% of company
—
Change vs last qtr
+61.0K (+3.8%)
Held since
Q3 '25

28 more super investors behind a free account

See every manager holding EUPRAXIA PHARMACEUTICALS INC., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting Eupraxia on Form N-PORT
FN
Fidelity Concord Street Trust
Position value
$257K
% of company
—
% of the fund
0.00%
As of
May 31, 2026
BA
Blackstone Alternative Investment Funds
Position value
$1.98K
% of company
—
% of the fund
0.00%
As of
June 30, 2026

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
JS
Joseph S. Freedman
5%+ holder13D · 9.0%
Shares
5.8M
% of company
—
Change vs last qtr
—
Held since
—

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support